Morphometric analysis in neurodegenerative disorders.
The study of dendritic length and spine density has become a standard in the analysis of neuronal abnormalities since a considerable number of neurological diseases have their foundation in alterations in these structures. One of the best ways to study possible alterations in neuronal morphometry is the use of Golgi impregnation. Introduced more than a century ago, it is still the standard and state-of-the-art technique for visualization of neuronal architecture. We successfully applied the Golgi method to mouse, rat, monkey and human brain tissues for studying both the normal and abnormal morphology of neurons. We were able to discover subtle morphological alterations in neuronal dendrites and dendritic spines in different brain areas. Although Golgi preparations can be examined by electronic microscopy, we used light microscopy and Neurolucida reconstruction to quantitatively explore the relationship between total dendritic length and spine density in different types of neurons. This review summarizes the methodology used to quantify neuronal abnormalities and discusses the utility of these techniques in different models of neurodegeneration.
Milatovic
Dejan
D
Vanderbilt University School of Medicine, Nashville, TN, USA.
Montine
Thomas J
TJ
Zaja-Milatovic
Snjezana
S
Madison
Jennifer L
JL
Bowman
Aaron B
AB
Aschner
Michael
M
D000818:Animals; D001921:Brain / Q000648:ultrastructure*; D003712:Dendrites / Q000648:ultrastructure*; D049229:Dendritic Spines / Q000648:ultrastructure; D016591:Histocytological Preparation Techniques / Q000379:methods*; D006801:Humans; D019636:Neurodegenerative Diseases / Q000473:pathology*; D011689:Purkinje Cells / Q000648:ultrastructure
J Neurosci Methods. 1996 May;66(1):55-9
8794940
Stain Technol. 1983 Mar;58(2):79-84
6194584
Toxicol Appl Pharmacol. 2009 Oct 15;240(2):124-31
19615394
Behav Brain Res. 2005 Aug 30;163(1):78-90
15913801
Toxicol Appl Pharmacol. 2009 Oct 15;240(2):219-25
19607852
J Neurochem. 2003 Dec;87(6):1518-26
14713307
J Neurol Neurosurg Psychiatry. 1998 Oct;65(4):446-53
9771764
J Neurosci. 2002 Jun 1;22(11):RC225
12040084
J Neurosci. 2007 Mar 7;27(10):2472-82
17344385
J Neurochem. 2002 Oct;83(2):463-70
12423256
Hippocampus. 2009 Sep;19(9):828-36
19235231
Parkinsonism Relat Disord. 2007;13 Suppl 3:S251-8
18267246
Microsc Res Tech. 1992 Dec 1;23(4):264-74
1295612
Cereb Cortex. 2009 Nov;19(11):2719-27
19293395
J Anat. 1964 Jul;98:327-44
14193193
Toxicol Appl Pharmacol. 2007 Mar;219(2-3):97-105
17188316
Front Biosci. 2006 Sep 01;11:2746-58
16720347
J Neurosci Methods. 1984 Sep;11(4):221-30
6392756
J Comp Neurol. 2005 May 23;486(1):39-47
15834963
J Neurosci Methods. 2009 Jan 30;176(2):72-7
18789970
Cereb Cortex. 2000 Oct;10(10):1038-44
11007554
J Neurocytol. 1989 Feb;18(1):27-38
2468741
Arch Gen Psychiatry. 2000 Jan;57(1):65-73
10632234
Cereb Cortex. 2000 Oct;10(10):981-91
11007549
Neurotoxicology. 2008 Jul;29(4):621-7
18556069
J Histochem Cytochem. 1994 Mar;42(3):393-403
7508472
J Comp Neurol. 1990 Sep 1;299(1):89-105
2212113
Prog Brain Res. 2005;147:29-37
15581695
Neurology. 2005 Feb 8;64(3):545-7
15699393
Neuroscience. 1987 Feb;20(2):577-87
2438593
J Neurosci Methods. 1981 Aug;4(2):117-25
6168870
J Neurosci Methods. 1998 Jan 31;79(1):1-4
9531453
Nat Neurosci. 2006 Feb;9(2):251-9
16415865
J Neuroinflammation. 2004 Oct 21;1(1):20
15498098
Brain Res Brain Res Rev. 2002 Jun;39(1):29-54
12086707
J Neuropathol Exp Neurol. 1982 Sep;41(5):500-7
6180137
Biol Psychiatry. 2004 Jun 15;55(12):1121-7
15184030
Mol Neurobiol. 2008 Feb;37(1):73-82
18438727
J Anat. 1953 Oct;87(4):387-406
13117757